New Treatment Modality for better dermal remodeling

Syneron Medical Ltd. has presented a groundbreaking treatment modality at the 5-Continent-Congress for Lasers and Aesthetic Medicine in Nice on September 10th, 2009. The company introduced a new and unique treatment modality called Sublative Rejuvenation™, which answers the skin rejuvenation market’s emerging demand for optimal efficiency, minimal downtime and an affordable procedure price point. Next presentation of the Sublative Rejuvenation will be given at the 18th Congress of the Academy of Dermatology and Venereology (EADV) in Berlin, Germany.
Recent scientific evaluations using eMatrix™, led to the identification of Sublative Rejuvenation, a new treatment modality that goes beyond current fractional skin ablation and resurfacing methods. “With sublative rejuvenation, the results are remarkable. After 3 treatments we can see remarkable improvement in skin tone, brightness, texture, small wrinkles and even acne scars. As radio waves induce dermal heating and collagen remodelling we can also see tissue tightening with continual improvement in the months to follow. Results from the device make deep chemical peels a thing of the past”, says Dr. Ines Verner, dermatologist from Israel.
Sublative Rejuvenation utilizes a fractionated bi-polar radio frequency technology in which heat energy is effectively placed into the dermis, producing significant dermal remodeling with minimal epidermal disruption. While traditional fractional technologies are most aggressive at the epidermal level, Sublative Rejuvenation delivers energy that creates a triangular-shaped pattern of impact where the ablated zone on the skin’s surface is narrower and minimized. The ablative and particularly coagulative zone widens below the surface, reflecting the higher heating of the deeper zones of the dermal connective tissue and collagen. This specific, sublative targeting maximizes clinical results and reduces downtime and risk of adverse reaction. Increased dermal heating leads to stronger collagenesis, making Sublative Rejuvenation most desirable for wrinkle reduction as well as overall textural improvement and luminosity for all skin types. “Patients think it’s fabulous. They find it to be very tolerable. I like that it works even on old acne scars that have been previously resistant to therapy” says Stephen Bassett, M.D., an aesthetic practitioner and medical director of ShapeCYMRU Swansea, Wales, U.K.
“Before the introduction of Sublative Rejuvenation with eMatrix, I needed to be extremely careful when performing any kind of ablative or even non-ablative treatment on my patients with darker skin tones because of possible adverse reactions,” said Hema Sundaram, M.D., F.A.A.D., a board certified dermatologist in Washington, D.C. “In my experience with eMatrix, there have been no cases of post-inflammatory hyperpigmentation, the most common complication observed when performing any type of laser resurfacing treatment on patients with darker skin tones. This finding is unique and extremely exciting.”

Syneron Medical Ltd. (NASDAQ: ELOS) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elōs™ combined-energy technology of bi-polar radio frequency and light. The company's innovative elōs technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle treatment, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, the treatment of acne, leg veins, cellulite and (thighs) circumferences reduction, body conturing as well as laser assisted lipolysis. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American headquarters in Irvine, California, and Asia-Pacific headquarters in Hong Kong, which provide sales, service and support.

Mira Martz
-PR Consultant-
ART.media Public Relations
Inhaber Michael Gillner
Stromstrasse 4
10555 Berlin, Germany
Steuernr.: 46/215/00901
Phone: +49 (0) 30 – 740 744 749
Fax: +49 (0) 30 - 740 744 755
mira_martz@art-media.eu
www.art-media.eu

This release was published on openPR.